Serum levels of AREG were higher in 41 patients with colorectal cancer (stage IV or recurrent group, median = 31.55 pg/mL) than in the stage I–III group (78 patients, median = 15.48 pg/mL) [28]. The gene discussed is AREG; the disease is colorectal cancer.